RenovoRx Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | -200.0% | – | +0.0% | +400.0% | – | |
| – | -7.5% | +91.4% | -42.3% | +4.5% | -1.2% | +14.3% | +19.8% | +1.2% | -18.3% | +11.2% | +79.8% | – | |
| – | – | – | – | -28.4% | -155.7% | – | – | – | -73.5% | -630.5% | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | +7.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -207.6% | – | |
| – | – | – | +78.0% | -99.8% | +120.0% | +32,660.6% | -99.7% | -100.0% | – | – | -99.4% | – | |
| – | – | – | +128.6% | -129.6% | – | – | -130.5% | – | – | – | -154.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.